Showing 2191-2200 of 5771 results for "".
- Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseaseshttps://modernod.com/news/exonate-announces-collaboration-with-janssen-to-develop-a-new-eye-drop-for-the-treatment-of-retinal-vascular-diseases/2477223/Exonate, an early stage biotechnology company, announced that it has entered into a strategic collaboration agreement with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Through the collaboration, Exonate will work with Janssen Research & Development scientists to develop an
- AbbVie Announces Leadership Team and Creation of New Business, Allergan Aesthetics, Upon Completion of Acquisitionhttps://modernod.com/news/abbvie-announces-leadership-team-and-creation-of-new-business-allergan-aesthetics-upon-completion-of-acquisition/2477216/AbbVie announced the creation of a new global business, Allergan Aesthetics, and the proposed leadership team for the combined company, effective upon the expected first-quarter 2020 close of the Allergan acquisition. Allergan Aesthetics will operate as a new global dedicated business wit
- Acucela Announces Publication Assessing the Role of Emixustat Hydrochloride in Retinal Degeneration Treatmenthttps://modernod.com/news/acucela-announces-publication-assessing-the-role-of-emixustat-hydrochloride-in-retinal-degeneration-treatment/2477209/Acucela announced the publication of an article concerning the company’s investigational drug candidate, emixustat hydrochloride (emixustat), in the scientific journal Drug Discovery Today. The published article, “Pharmacotherapy for Metabolic and Cellular Stress in Degenerative R
- IrisVision and Samsung Announce Partnership to Bring Clinically Validated Vision Technologies to Over 200 Million Low Vision Patients Globallyhttps://modernod.com/news/irisvision-and-samsung-announce-partnership-to-bring-clinically-validated-vision-technologies-to-over-200-million-low-vision-patients-globally/2477207/Samsung Electronics and IrisVision announced a strategic partnership to roll out IrisVision’s technology worldwide. IrisVision’s vision correction software platform uses the power of Samsung’s Galaxy smartphones, XR devices, and mobile AI platform to enable people
- DORC Announces FDA Approval of TissueBlue for Staining of the ILM During Vitreoretinal Surgeryhttps://modernod.com/news/dorc-announces-fda-approval-of-tissueblue-for-staining-of-the-ilm-during-vitreoretinal-surgery/2477204/Dutch Ophthalmic Research Centre (DORC) announced it has received FDA approval for TissueBlue (Brilliant Blue G Ophthalmic Solution) 0.025%. TissueBlue is the first FDA-approved dye for use as an aid in ophthal
- Aerie Pharmaceuticals Announces Acceptance for Review of the Roclanda Marketing Authorization Application in Europehttps://modernod.com/news/aerie-pharmaceuticals-announces-acceptance-for-review-of-the-roclanda-marketing-authorization-application-in-europe/2477200/Aerie Pharmaceuticals announced that the European Medicines Agency (EMA) has accepted for review the marketing authorization application (MAA) for Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%. Roclanda is currently marketed as Rocklatan in the United States, where it is
- Acucela Announces Publication of Preclinical Data for Emixustat Hydrochloridehttps://modernod.com/news/acucela-announces-publication-of-preclinical-data-for-emixustat-hydrochloride-2/2477190/Acucela announced the publication of preclinical data related to the company’s investigational drug candidate, emixustat hydrochloride (emixustat), in the scientific journal Investigative Ophthalmology & Visual Science (IOVS). The published article, “Emixustat reduces metaboli
- Midwest Vision Partners Announces Partnership With Cleveland Eye Clinichttps://modernod.com/news/midwest-vision-partners-announces-partnership-with-cleveland-eye-clinic/2477186/Eye care management company Midwest Vision Partners (MVP) has announced its partnership with Cleveland Eye Clinic (CEC). Terms of the deal were not disclosed. MVP’s partnership with CEC expands its network to 19 locations in Ohio with 33 physicians providing medical and surgic
- Aldeyra Therapeutics Announces First Patient Enrolled in the Phase 3 GUARD Trial for Prevention of Proliferative Vitreoretinopathyhttps://modernod.com/news/aldeyra-therapeutics-announces-first-patient-enrolled-in-the-phase-3-guard-trial-for-prevention-of-proliferative-vitreoretinopathy/2477182/Aldeyra Therapeutics announced enrollment of the first patient into the phase 3 GUARD Trial of ADX-2191 for the prevention of proliferative vitreoretinopathy (PVR). PVR is a serious, sight-threatening retinal disease with no approved treatment. “Initiation of patient enrollment in the GUAR
- Staar Surgical Announces Strategic Alliance Agreement with California Center for Refractive Surgery (CCRS)https://modernod.com/news/staar-surgical-announces-strategic-alliance-agreement-with-california-center-for-refractive-surgery-ccrs/2477178/Staar Surgical announced it has entered into a strategic alliance with the California Center for Refractive Surgery (CCRS), a Los Angeles based eye care group with locations in Hancock Park and Sherman Oaks. “Our new multi-clinic alliance with CCRS and its founder Dr. Paul Lee is represent